Early age at onset of breast cancer (eoBC) is suggestive of an increased genetic risk. Although genetic testing is offered to all eoBC-affected women, in isolated cases the detection rate of pathogenic variants is 60% and loss of heterozygosity at chromosome 17q. The patient hypermethylated at RAD51C showed low methylation in the tumor sample, ruling out a role for methylation-induced silencing in tumor development. In isolated eoBC patients, BRCA1 constitutive promoter methylation may be a predisposing event. Further studies are required to define the impact of methylation changes occurring at BC-predisposing genes and their role in tumorigenesis
The role of gene-specific methylation in white blood cells (WBC) as a marker of breast cancer risk i...
Background: Inherited mutations in the BRCA1 gene may be responsible for al-most half of inherited b...
The initiation and progression of breast cancer have been recognized for many years to be secondary ...
Early age at onset of breast cancer (eoBC) is suggestive of an increased genetic risk. Although gene...
Previous studies on breast and ovarian carcinoma (BC and OC) revealed constitutional BRCA1 and RAD51...
Women carrying germline mutations in BRCA1 are at a substantially elevated risk of breast cancer and...
Promoter-CpG island hypermethylation is a common molecular defect in cancer cells. It has been propo...
Promoter-CpG island hypermethylation is a common molecular defect in cancer cells. It has been propo...
Male breast cancer (MBC) is a rare disease. Due to its rarity, MBC research and clinical approach ar...
Importance About 25% of all triple-negative breast cancers (TNBCs) and 10% to 20% of high-grade ser...
Mutations in BRCA1/2 genes are involved in the pathogenesis of breast and ovarian cancer. Inactivati...
INTRODUCTION: Individuals with germline mutations in the BRCA1 gene have an elevated risk of develop...
Introduction: Individuals with germline mutations in the BRCA1 gene have an elevated risk of develop...
The role of gene-specific methylation in white blood cells (WBC) as a marker of breast cancer risk i...
Cancer is caused by genetic and epigenetic changes resulting in altered patterns of gene expression....
The role of gene-specific methylation in white blood cells (WBC) as a marker of breast cancer risk i...
Background: Inherited mutations in the BRCA1 gene may be responsible for al-most half of inherited b...
The initiation and progression of breast cancer have been recognized for many years to be secondary ...
Early age at onset of breast cancer (eoBC) is suggestive of an increased genetic risk. Although gene...
Previous studies on breast and ovarian carcinoma (BC and OC) revealed constitutional BRCA1 and RAD51...
Women carrying germline mutations in BRCA1 are at a substantially elevated risk of breast cancer and...
Promoter-CpG island hypermethylation is a common molecular defect in cancer cells. It has been propo...
Promoter-CpG island hypermethylation is a common molecular defect in cancer cells. It has been propo...
Male breast cancer (MBC) is a rare disease. Due to its rarity, MBC research and clinical approach ar...
Importance About 25% of all triple-negative breast cancers (TNBCs) and 10% to 20% of high-grade ser...
Mutations in BRCA1/2 genes are involved in the pathogenesis of breast and ovarian cancer. Inactivati...
INTRODUCTION: Individuals with germline mutations in the BRCA1 gene have an elevated risk of develop...
Introduction: Individuals with germline mutations in the BRCA1 gene have an elevated risk of develop...
The role of gene-specific methylation in white blood cells (WBC) as a marker of breast cancer risk i...
Cancer is caused by genetic and epigenetic changes resulting in altered patterns of gene expression....
The role of gene-specific methylation in white blood cells (WBC) as a marker of breast cancer risk i...
Background: Inherited mutations in the BRCA1 gene may be responsible for al-most half of inherited b...
The initiation and progression of breast cancer have been recognized for many years to be secondary ...